Cargando…
Enhanced sensitivity of laforin- and malin-deficient mice to the convulsant agent pentylenetetrazole
Lafora disease is a rare form of inherited progressive myoclonus epilepsy caused by mutations in the EPM2A gene encoding laforin, or in the EPM2B gene, which encodes malin. It is characterized by the presence of polyglucosan inclusion bodies (Lafora bodies) in brain and other tissues. Genetically en...
Autores principales: | García-Cabrero, Ana M., Sánchez-Elexpuru, Gentzane, Serratosa, José M., Sánchez, Marina P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162417/ https://www.ncbi.nlm.nih.gov/pubmed/25309313 http://dx.doi.org/10.3389/fnins.2014.00291 |
Ejemplares similares
-
Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy
por: Mitra, Sharmistha, et al.
Publicado: (2023) -
Tau-Induced Pathology in Epilepsy and Dementia: Notions from Patients and Animal Models
por: Sánchez, Marina P., et al.
Publicado: (2018) -
The laforin/malin E3-ubiquitin ligase complex ubiquitinates pyruvate kinase M1/M2
por: Viana, Rosa, et al.
Publicado: (2015) -
The Laforin–Malin Complex, Involved in Lafora Disease, Promotes the Incorporation of K63-linked Ubiquitin Chains into AMP-activated Protein Kinase β Subunits
por: Moreno, Daniel, et al.
Publicado: (2010) -
Structural and Functional Brain Abnormalities in Mouse Models of Lafora Disease
por: Burgos, Daniel F., et al.
Publicado: (2020)